在癌症干细胞中免疫逃逸的表观遗传控制
Claudia Galassi1, Manel Esteller2, Ilio Vitale3
1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Trends in cancer
|September 7, 2024
概括
癌症干细胞 (CSCs) 通过表观遗传修饰逃避免疫反应. 针对这些表观遗传改变可能会提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤的进展,治疗耐药性和复发.
- 与差异化癌细胞相比,CSC具有更强的抗压能力和免疫逃避能力.
- 免疫逃避是整个癌症进展过程中的关键因素.
研究的目的:
- 要总结CSC用于免疫逃避的表观遗传机制.
- 确定CSC中的表观遗传变化作为潜在的治疗点.
主要方法:
- 审查关于CSCs和免疫逃避的现有文献.
- 在CSCs的表观遗传修饰 (DNA和基因组) 的分析.
- 综合发现,提出治疗策略.
主要成果:
- CSCs使用特定的表观遗传修饰来避免免疫检测和消除.
- 这些表观遗传变化有助于CSCs对宿主免疫力的弹性.
- CSCs的表观遗传景观在他们的免疫特权地位中起着至关重要的作用.
结论:
- 表观遗传修饰是CSC免疫逃避的关键.
- 向特定于CSC的表观遗传变化提供了一个有希望的策略,使瘤对免疫疗法敏感.
- 开发可逆转这些表观遗传变化的疗法可以克服治疗耐药性和复发.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


